MissionIR Articles

Nutriband Inc. (NTRB)

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, has selected IBN to manage its corporate communications and investor outreach. Soligenix is advancing late-stage clinical programs through its oncology and inflammation-focused Specialized BioTherapeutics segment…

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced that it is making its Advantage™ quantum computing systems available for purchase by research centers, academic institutions, and governments, enabling on-premises quantum experimentation and development. D-Wave expects the move,…

McEwen Mining (NYSE: MUX) (TSX: MUX) announced a significant increase in estimated gold resources at the Grey Fox deposit within its Fox Complex as of Dec. 31, 2024, compared to its 2021 estimate. The discovery…

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and…

SuperCom (NASDAQ: SPCB), a global provider of e-Government, IoT, and cybersecurity solutions, announced two new contracts with key Kentucky agencies to deploy its advanced public safety technologies. The contracts, which displaced incumbent competitors, demonstrate SuperCom’s growing…

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) was featured in a recent article by Simply Wall St. The publication describes Platinum’s ownership structure, explaining that the company is primarily owned by individual investors,…

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced participation at the H.C. Wainwright 26th Annual Global Investment Conference. The conference,…

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company…

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, is featured in a NetworkNewsAudio (“NNA”) broadcast. NNA broadcasts are designed…

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced receipt of approval from the U.S. Food and Drug…

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into securities purchase agreements with health-care focused…

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug-platform company developing novel therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting the results of its recent phase 2/3 Alzheimer’s study. The study…

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, acquires value-add real estate within the regulated U.S. cannabis industry with selective development innovation and aspirations to spearhead direct-to-consumer real…